financial_disclosure

Hyderabad – September 10, 2026 -- Jassper Shipping has announced a growth capital programme of up to US$50 million to be deployed over the next three years, subject to market conditions and regulatory approvals, positioning India as the hub for its expansion into the Gulf, Southeast Asia, Africa, the Red Sea and the Far East.

Phase 1 commits $10 million to project logistics serving power and steel sectors

Under the first phase, Jassper Shipping intends to deploy US$10 million to its B2B project logistics business, targeting sectors it already serves: power, steel, petrochemicals, heavy engineering, manufacturing and large infrastructure.

Stockholm – – September 10, 2026 -- EQT AB has completed its share buyback program after repurchasing 4,368,899 own ordinary shares for a total of SEK 1,448,620,146.93, the private equity firm confirmed.

EQT finalizes buyback authorization after hitting maximum share count

Between August 31 and September 4, 2026, EQT repurchased 707,203 ordinary shares (ISIN: SE0012853455) on Nasdaq Stockholm, closing out a program launched July 20, 2026. The initiative, announced May 12, 2026, authorized purchases of up to 4,368,899 shares for a maximum of SEK 2,500,000,000, carried out under the EU Market Abuse Regulation No 596/2014 and Commission Delegated Regulation No 2016/1052.

Frankfurt – September 09, 2026 -- Cyberattack frequency against European mid-sized companies fell to a five-year low in 2025, yet the average claim value tripled between 2020 and 2025, according to Chubb's Cyber Claims Report 2026.

Claim frequency drops while financial severity climbs sharply

Chubb's data shows that while the number of cyber incidents affecting mid-market firms stabilized and declined to its lowest point in five years during 2025, the cost per claim has risen threefold over the preceding five-year period. The insurer attributes the gap partly to artificial intelligence, which is simultaneously helping companies detect vulnerabilities and enabling more sophisticated malicious use of technology that accelerates the scale of exposure.

Halle – September 09, 2026 -- The insolvent chemical producer Leuna Polyamid has failed to secure a binding investor offer for its large plant in Leuna, Saxony-Anhalt, putting roughly 400 jobs at risk of permanent loss.

No binding investor offer has been received, CEO confirms

"We have unfortunately not yet received a binding offer from an investor," managing director Martin Naundorf told the Mitteldeutsche Zeitung. The company had been searching for a buyer to keep the polyamide and fertilizer production site operational.

Production continues through September to fulfill existing customer orders

The plant will keep running until the end of September to complete outstanding customer contracts, according to Naundorf. After that, management plans to shut down the facility itself, a process expected to take 15 to 20 days.

Chicago – September 09, 2026 -- CME Group's FX futures and options open interest climbed to a record 4,410,167 contracts on September 4, 2026, eclipsing the prior high of 4,269,622 contracts set on June 11, 2026.

Large open interest holders reach all-time high of 1,446

The number of large open interest holders in FX futures hit an all-time high of 1,446, according to the CFTC's Commitment of Traders report dated August 25, 2026.

Asset managers surpass $200 billion in FX futures notional exposure

Asset managers exceeded $200 billion in FX futures notional open interest for the first time, marking a new threshold for buy-side participation in the market.

Delray Beach, Fla. – September 09, 2026 -- The global automotive ECU market is projected to expand from $113.27 billion in 2026 to $160.59 billion by 2033, a 5.1% compound annual growth rate, according to MarketsandMarkets.

Aachen – September 09, 2026 -- devolo has issued a digital corporate bond through the regulated CONDA Capital Market platform to fund a growth initiative spanning new Wi-Fi 7 and Wi-Fi 8 hardware, AI-driven software and expanded European sales operations.

devolo diversifies financing beyond traditional bank credit

The Aachen-based home networking and powerline specialist, which has sold more than 50 million products and holds over 1,000 international test awards, is turning to capital markets to accelerate its expansion plans independently of banks. Dr. Paul Niederkofler, Managing Partner at SOL Capital Management, the company's majority financial investor, said the digital bond builds on an equity ratio of roughly 67% in 2025, including shareholder loans, to give devolo an additional financing channel to speed up growth.

Easton, Pennsylvania – September 09, 2026 -- Eightco Holdings Inc. (NASDAQ: ORBS) disclosed total treasury holdings of approximately $380 million as of September 2, 2026, at 8:00 p.m. ET, anchored by indirect stakes in OpenAI and Beast Industries alongside large digital-asset positions.

Eightco holds $90 million in OpenAI via SPVs, representing 24% of treasury assets

The company's indirect exposure to OpenAI's parent, structured through special purpose vehicles, marks one of the largest disclosed concentrations in the AI leader among publicly traded firms.

Shanghai – September 09, 2026 -- Harbour BioMed (HKEX: 02142.HK) shares became eligible for trading under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, opening direct access for qualified mainland Chinese investors effective immediately.

Market capitalization crosses HK$10 billion threshold

The inclusion follows the Company's market capitalization steadily surpassing HK$10 billion, placing it among large- and mid-cap biopharmaceutical issuers on the Hong Kong exchange.

First-half 2026 revenue rises 20.9% to $122.5 million

Harbour BioMed recorded total revenue of approximately US$122.5 million in the first half of 2026, up 20.9% year-over-year. Adjusted net profit reached approximately US$71.6 million, marking seven consecutive profitable half-years. Cash and cash equivalents stood at approximately US$359.2 million as of June 30, 2026.

Shanghai – September 09, 2026 -- Clover Biopharmaceuticals (HKEX: 02197) reported positive preliminary Phase 2 data in Australia for two combination respiratory vaccine candidates, SCB-1022 (RSV+hMPV) and SCB-1033 (RSV+hMPV+PIV3), targeting older adults aged 60-85.

Trial enrolled 420 older adults across multiple Australian sites

The randomized, observer-blinded study randomized 420 participants to receive SCB-1022, SCB-1033 or placebo. Antibody titers at 28 days post-vaccination were in line with or trended higher than prior Phase 1 results.